US Broker Ratings

ADMA Biologics Inc (ADMA): Unlocking 48.64% Upside Potential with Robust Revenue Growth

ADMA Biologics Inc (NASDAQ: ADMA), a leading player in the biotechnology sector, is capturing investor attention with its strong growth trajectory and promising future prospects. Specializing in the development and..

Bruker Corporation (BRKR): Exploring Its 50% Upside Potential and Strategic Position in the Medical Devices Sector

Bruker Corporation (NASDAQ: BRKR) stands out as a compelling player in the medical devices industry, offering a diverse portfolio of scientific instruments and diagnostic solutions that cater to a broad..

BrightSpring Health Services, I (BTSG) Investor Outlook: Analyzing a Potential 13.97% Upside

BrightSpring Health Services, Inc. (BTSG) has captured investor attention in the healthcare sector with its significant growth potential and robust market presence. Operating as a home and community-based healthcare services..

Prestige Consumer Healthcare (PBH) Stock Analysis: A Healthcare Player with a 3.30% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH) has established itself as a notable player in the healthcare sector, focusing on over-the-counter (OTC) health and personal care products. The company’s extensive portfolio..

Sarepta Therapeutics (SRPT) Investor Outlook: Exploring the 139% Potential Upside in Biotech Innovation

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a pioneering force in the biotechnology sector, is making waves in the healthcare industry with its cutting-edge RNA-targeted therapeutics and gene therapies. As the company..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 53.72% Potential Upside

Investors with a keen eye on the healthcare sector, particularly in biotechnology, may find Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) a compelling investment opportunity. With a market capitalization of $6.11 billion,..

Encompass Health Corporation (EHC) Investor Outlook: Analyzing Growth Potential Amid a Promising 8.58% Upside

Encompass Health Corporation (NYSE: EHC) stands out in the healthcare sector, boasting a robust market cap of $12.19 billion. As a leading provider of post-acute healthcare services, Encompass Health operates..

Genmab A/S (GMAB) Stock Analysis: Unveiling a 39.92% Potential Upside in the Biotech Sector

Genmab A/S (NASDAQ: GMAB), the Danish biotechnology powerhouse, continues to make waves in the healthcare sector with its innovative antibody-based treatments targeting cancer and other severe diseases. With a market..

Walgreens Boots Alliance, Inc. (WBA) Stock Analysis: Evaluating the 8.89% Dividend Yield Amidst Market Challenges

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) stands as a complex player in the healthcare and pharmaceutical retail sector, offering investors a blend of both opportunity and risk. As an established..

BioNTech SE (BNTX) Stock Analysis: Analyst Ratings Favor a 38% Upside Potential

BioNTech SE (NASDAQ: BNTX), a German biotechnology powerhouse, continues to intrigue investors with its innovative approaches to treating cancer and infectious diseases. With a market capitalization of $23.03 billion, this..

Incyte Corporation (INCY) Stock Analysis: Uncovering a 13.56% Potential Upside in Biotech Innovation

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, stands out with its innovative therapeutic offerings and a promising potential upside of 13.56%, making it a compelling consideration..

Zoetis Inc. (ZTS) Stock Report: Analyst Ratings Highlight 15% Potential Upside for Investors

Zoetis Inc. (NYSE: ZTS), a leading player in the healthcare sector, is making waves in the animal health industry. With a market capitalization of $75.08 billion, Zoetis is a powerhouse..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Unveiling a 54.54% Potential Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP) is captivating the attention of investors with a noteworthy potential upside of 54.54%, according to analyst ratings. Positioned in the healthcare sector, this medical..

Ionis Pharmaceuticals (IONS) Stock Analysis: Exploring a 71.71% Upside Potential

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a prominent player in the biotechnology sector, is captivating investor interest with its promising pipeline of RNA-targeted medicines and a substantial potential upside of 71.71%...

Molina Healthcare Inc (MOH) Stock Analysis: Exploring an 18.10% Potential Upside in Healthcare Plans

Molina Healthcare Inc (NYSE: MOH) has long been a stalwart in the healthcare plans sector, providing essential managed healthcare services to low-income families and individuals across the United States. With..

Elanco Animal Health (ELAN) Stock Analysis: Assessing the 8.23% Potential Upside

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a significant player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $6.67..

Charles River Laboratories (CRL) Stock Analysis: Navigating the Healthcare Diagnostics Sector with a 17.19% Upside Potential

Charles River Laboratories International, Inc. (NYSE: CRL) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $6.66 billion, the..

Exact Sciences Corporation (EXAS) Stock Analysis: A 22.3% Potential Upside in the Healthcare Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS), a prominent player in the healthcare diagnostics sector, is drawing significant attention from investors due to its innovative cancer screening and diagnostic test products. With..

Medtronic plc (MDT) Stock Analysis: Navigating a 15% Upside Potential Amidst Steady Growth

Medtronic plc (NYSE: MDT), a prominent player in the healthcare sector, is gaining attention from investors due to its robust market presence and potential upside. With a market capitalization of..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 9.14% Potential Upside in the Healthcare Sector

Henry Schein, Inc. (NASDAQ: HSIC) is a major player in the healthcare sector, specializing in medical distribution. With a market capitalization of $8.75 billion, the company serves as a pivotal..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds